Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.

Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus (“staph”) bacteria, is particularly challenging to treat.

Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface.

A team of Vanderbilt researchers has provided important validation of maps of the brain at rest that may offer insights into changes in the brain that occur in neurological and psychiatric diseases.

Chancellor Nicholas S. Zeppos and other state leaders met with members of Tennessee’s congressional delegation in Washington, D.C., to urge support for sustained federal investments in science and engineering research.